“People should not be forced to go into debt to get lifesaving prescriptions,” said Governor Gavin Newsom.

Don’t let Eli Lilly’s latest P.R. stunt fool you: Private companies shouldn’t be allowed to set prices for these lifesaving drugs in the first place.

Lawmakers are touting a proposed cap on prices, but the benefit won’t swing to the patients with the most desperate needs.

The big-box retailer has found a way to monetize the nation’s desperation.

The staggeringly high costs of good health in America affect all of us in profound ways—and insulin makes the stakes tragically clear.

The controversial proposed deal with Purdue Pharma hints at better alternatives to for-profit pharmaceutical companies.